» Articles » PMID: 6809291

Bone Acid Phosphatase: Tartrate-resistant Acid Phosphatase As a Marker of Osteoclast Function

Overview
Specialty Pathology
Date 1982 May 1
PMID 6809291
Citations 205
Authors
Affiliations
Soon will be listed here.
Abstract

Organ cultures of newborn mouse calvaria were used to test the hypothesis that tartrate-resistant acid phosphatase might serve as a biochemical marker for osteoclast function. When bone resorption was stimulated in vitro with either parathyroid hormone or 1,25(OH)2D3, there was a significant increase in both tartrate-resistant and tartrate-sensitivity acid phosphatase activity in the medium relative to cultured controls. Tartrate-resistant activity was localized histochemically primarily over the osteoclast and appeared as three distinct activity bands when electrophoresed on polyacrylamide gels. The tartrate-sensitive activity was found primarily associated with bone cells other than the osteoclast using histochemical techniques, and was resolved into five bands on polyacrylamide gels. The results obtained from biochemical assays, histochemical observations, and polyacrylamide gel electrophoresis suggest that bone resorption in vitro results in the release of tartrate-resistant acid phosphatase from osteoclasts and tartrate-sensitive acid phosphatase from other bone cells as well as osteoclasts. Tartrate-resistant acid phosphatases of bone may be suitable biochemical probes for osteoclasts function, but it will be necessary to achieve further purification in order to develop analytical methods with sufficient sensitivity and specificity (e.g., immunochemical) to ensure precise localization and quantitation.

Citing Articles

Geranylgeranyl diphosphate synthase inhibition impairs osteoclast differentiation, morphology, and resorptive activity.

Muehlebach M, Haney S, Chhonker Y, Rashid M, Murry D, Talmon G JBMR Plus. 2024; 9(1):ziae133.

PMID: 39697524 PMC: 11653010. DOI: 10.1093/jbmrpl/ziae133.


Cell fusion dynamics: mechanisms of multinucleation in osteoclasts and macrophages.

Sabe H, Yahara Y, Ishii M Inflamm Regen. 2024; 44(1):49.

PMID: 39605032 PMC: 11600601. DOI: 10.1186/s41232-024-00360-3.


Inhibition of inflammatory osteoclasts accelerates callus remodeling in osteoporotic fractures by enhancing CGRPTrkA signaling.

Shu Y, Tan Z, Pan Z, Chen Y, Wang J, He J Cell Death Differ. 2024; 31(12):1695-1706.

PMID: 39223264 PMC: 11618598. DOI: 10.1038/s41418-024-01368-5.


Preclinical models for the study of pediatric solid tumors: focus on bone sarcomas.

Petrescu D, Yustein J, Dasgupta A Front Oncol. 2024; 14:1388484.

PMID: 39091911 PMC: 11291195. DOI: 10.3389/fonc.2024.1388484.


Reprogramming macrophages with R848-loaded artificial protocells to modulate skin and skeletal wound healing.

Lopez-Cuevas P, Oates T, Tong Q, McGowan L, Cross S, Xu C J Cell Sci. 2024; 137(16).

PMID: 39078119 PMC: 11385641. DOI: 10.1242/jcs.262202.


References
1.
KAHN A, Stewart C, Teitelbaum S . Contact-mediated bone resorption by human monocytes in vitro. Science. 1978; 199(4332):988-90. DOI: 10.1126/science.622581. View

2.
Messer H, ARMSTRONG W, Singer L . Influence of calcitonin on bone phosphatases and phosphate release in organ culture. Proc Soc Exp Biol Med. 1973; 143(3):690-2. DOI: 10.3181/00379727-143-37392. View

3.
Li C, Yam L, Lam K . Acid phosphatase isoenzyme in human leukocytes in normal and pathologic conditions. J Histochem Cytochem. 1970; 18(7):473-81. DOI: 10.1177/18.7.473. View

4.
Anderson T, TOVERUD S . Purification and partial characterization of two acid phosphatases from rat bone. Calcif Tissue Int. 1979; 27(3):219-26. DOI: 10.1007/BF02441189. View

5.
Vaes G . On the mechanisms of bone resorption. The action of parathyroid hormone on the excretion and synthesis of lysosomal enzymes and on the extracellular release of acid by bone cells. J Cell Biol. 1968; 39(3):676-97. PMC: 2107541. DOI: 10.1083/jcb.39.3.676. View